Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...
In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...
A pharmacist warns that off-brand Ozempic, Zepbound, and other weight loss products carry undisclosed risks for consumers.
That’s according to a new Employer Health Benefits Survey from KFF (formerly the Kaiser Family Foundation). But while a ...
A growing number of employers are considering covering the blockbuster weight-loss drugs, several surveys show. Workers will ...
Medicare coverage of the drugs would up federal spending by $35 billion from 2026 to 2034. Meanwhile, CNBC tests Abbott’s ...
Currently, the only FDA-approved OTC weight loss drug is Alli, which uses a 60-milligram dose of orlistat versus 120 ...
WEDNESDAY, Oct. 9, 2024 (HealthDay News) -- When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and ...
New Yorkers are brazenly reselling prescription diabetic and weight ... “In addition, injectable weight loss drugs are often not covered by insurance, making some patients more likely to pay ...
The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...
Kourtney Kardashian’s new “GLP-1 Daily” pill is the ... the results patients obtain through prescription weight loss drugs. “They take smidgens of scientific fact and blow it out of ...